NEW YORK (GenomeWeb) – Focus Diagnostics today announced its Simplexa Group A Strep Direct kit has received 510(k) clearance from the US Food and Drug Administration for marketing in the US. 

The agency has also categorized the test as moderate complexity, which will allow some clinicians to perform the test directly. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

British Nobel laureates and Fields Medal winners warn that a 'hard' Brexit could harm science across the UK, the Guardian reports.

Vox reports on inequities in genetic research and efforts to address them.

The New York Times reports that Arizona State University's Lawrence Krauss is retiring following allegations of sexual misconduct.

In PNAS this week: de novo NUS1 mutations linked to Parkinson's disease risk, candidate hepatocellular carcinoma drivers, and more.